Localized Nitric Oxide Signaling Mediates Cardiac Mechano-Chemotransduction  by Jian, Zhong et al.
566a Tuesday, February 18, 20142857-Pos Board B549
Localized Nitric Oxide Signaling Mediates Cardiac Mechano-Chemo-
transduction
Zhong Jian, Huilan Han, Tieqiao Zhang, Jose Puglisi, Leighton T. Izu,
John Shaw, Yi-Je Chen, Rafael Shimkunas, Nipavan Chiamvimonvat,
Donald M. Bers, Kit S. Lam, Ye Chen-Izu.
UC Davis, Davis, CA, USA.
Cardiac myocytes contract against a mechanical afterload during each heart-
beat. We have developed a novel Cell-in-Gel system to impose 3D mechanical
stresses on single cardiac myocytes during contraction. Using this new tech-
nique, we identified key molecules involved in transducing mechanical stress
to alter Ca2þ dynamics. Increasing mechanical load causes enhanced contrac-
tility and elevated systolic Ca2þ transient that is mediated by nitric oxide syn-
thase (NOS). Increased load also causes a marked increase of diastolic
spontaneous Ca2þ sparks, and their suppression is only effected by inhibition
of nNOS but not eNOS. The differential effects on Ca2þ sparks may stem
from the two-fold closer physical proximity of nNOS vs. eNOS to ryanodine
receptors. In addition to NOS, NOX2 and CaMKII are also involved in the
mechano-chemotransduction pathways, which together fine-tune cardiac
contraction under mechanical load.
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Cardiomyocytes derived from human induced pluripotent stem cells (hIPS-
CM) are useful to understand basic structural and functional characteristics
of normal and diseased human heart cells. We investigated mechanical proper-
ties of hIPS-CM derived from unaffected and affected members of a family
harboring a dilated cardiomyopathy (DCM) mutation in cardiac troponin T
(cTnT), the tropomyosin binding unit of troponin. Patients with a cTnT point
mutation (R173W) develop DCM, which commonly leads to diastolic and sys-
tolic dysfunction and progressive heart failure. To study the shortening and
shortening velocity of normal and cTnT mutant hIPS-CM cells, cells were
plated on substrates with a relatively soft stiffness (160 kPa) molded from poly-
dimethylsiloxane and measured using a line scan method. Data were collected
using a Zeiss 710 confocal microscope. Visual observation of cells after 5 days
maturity on the PDMS substrates indicate a smaller percent of mutant (8%)
compared to normal (87%) hIPS-CM were spontaneously beating. Immunohis-
tochemistry showed that myofibril structure was better developed in normal
compared to cTnT mutation cells. Day 5 line scans revealed normal hIPS-
CM cells shorten more (0.47 mm) than mutant cTnT cells (0.32 mm); shortening
velocity was faster in normal (1.42 mm/s) compared to mutant cTnT cells (0.67
mm/s). Acute treatment (1 dose with a 10 min activation dwell time) with ome-
camtiv mecarbil (200nM), a cardiac myosin activator, increased the shortening
and shortening velocity of normal (0.78 mm at 1.85 mm/s) but not cTnT mutant
(0.32 mm at 0.70 mm/s) hIPS-CM cells. Although more studies are necessary,
these results suggest that cTnT may affect development of sarcomeres and
the regulation of contractility. Furthermore, the myosin activator omecamtiv
mecarbil may not be sufficient to rescue dysfunction in the cTnT mutation
R173W. [Funding: NIH T32HL07692, PO1HL62426]
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Parvalbumin (Parv), an EF-hand Ca2þ buffer, facilitates rapid relaxation in
fast-twitch muscle. Parv gene delivery to the heart has been studied as a ther-
apeutic strategy for diastolic heart failure, in which slow Ca2þ reuptake is an
important contributor. A limitation of WT-Parv in this context is the significant
trade-off between faster relaxation rate and blunting of contraction amplitude,
which occurs because WT-Parv sequesters Ca2þ too early in the cardiac cycle
and prematurely truncates sarcomere shortening in the facilitation of rapid
relaxation. Our laboratory recently demonstrated that an E/Q substitution
(ParvE101Q) at amino acid 12 of the EF-hand metal-ion binding loop increases
Mg2þ affinity and decreases Ca2þ affinity. Mechanistically, E/Q disrupts bi-
dentate Ca2þ binding at this site to reduce Ca2þ binding affinity. Functionally,
this substitution delays Ca2þ buffering compared to WT-Parv in cardiac myo-
cytes, which hastens relaxation without blunting contraction. Unexpectedly,
ParvE101Q increases contraction amplitude above that of untreated myocytesand independent of Ca2þ, leading to the hypothesis that sarcomere-localized
altered Mg2þ binding may contribute to the inotropic effect. In this work, to
further elucidate the role of EF-hand motif residue 12 in function, ParvE101Q
and ParvE101D-experessing cardiac myocytes are compared. Although both Q
and D substitutions are thought to bind Ca2þ in a monodentate manner,
ParvE101D may bind Mg2þ more strongly than ParvE101Q. Consistent with
this, in preliminary studies, ParvE101D enhanced contraction amplitude to a
greater extent than ParvE101Q. We will discuss these findings in the context
of the mechanistic role of EF-hand loop residue 12 in conferring Ca2þ and
Mg2þ binding affinities with the goal of optimizing a Ca2þ buffering system
for heart failure.
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Phospholamban and sarcolipin interact with the sarcoplasmic reticulum cal-
cium pump (SERCA) and regulate contractility in smooth, cardiac and skeletal
muscle. While both proteins can form oligomers, it is thought that only the
monomers interact with and inhibit SERCA. To address the role of the phos-
pholamban and sarcolipin pentamers, we have studied their interaction with
SERCA using electron cryo-microscopy of two-dimensional co-crystals. In
our previous studies, phospholamban oligomers were found interspersed be-
tween SERCA dimers and we constructed a three-dimensional model of the
complex. We also addressed the molecular characteristics of phospholamban
that contribute to its interaction with SERCA and we examined the effects of
phosphorylation and mutation of phospholamban on the structure of the com-
plex with SERCA. In our recent work, we compared two crystal forms of
SERCA in the absence and presence of phospholamban by electron cryo-
microscopy - namely, small helical crystals and large two-dimensional crystals.
The SERCA dimer ribbons that are found in both crystal forms consist of a rigid
assembly of calcium-free SERCA molecules. While the lattice formed by the
SERCA dimer ribbons is different in the helical and two-dimensional crystals,
we show that a phospholamban oligomer interacts with SERCA in a similar
manner in both crystal types. With this information, we next undertook a struc-
tural investigation of SERCA and sarcolipin in the two-dimensional crystals. A
projection map was determined for SERCA in the presence of sarcolipin to a
resolution of 8.5 A˚ and was consistent with a pentameric state for sarcolipin.
While both phospholamban and sarcolipin interacted with transmembrane
segment M3 of SERCA, the interaction of the sarcolipin pentamer was medi-
ated by an additional density consistent with a SLN monomer. We conclude
that pentameric forms of both phospholamban and sarcolipin naturally asso-
ciate with SERCA.
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A naturally occurring missense Leu-39stop (L39X) mutation in phospholam-
ban (PLB) results in truncation of the C-terminal transmembrane domain, lead-
ing to cardiomyopathy and premature death. In this study, we fused PLB and
SERCA to fluorescent protein tags to determine the structural and thermody-
namic consequences of progressive truncations of the C-terminal residues of
PLB in the membranes of living cells. We found that deletion of only a few
C-terminal residues resulted in significant loss of PLB membrane anchoring
and mislocalization to the cytoplasm and nucleus. Selective permeabilization
of the plasma membrane by saponin resulted in diffusion of fluorescently
labeled PLB out of the cells, consistent with solubilization of truncated pro-
teins. Western blot analysis showed the expected mobilities for truncation mu-
tants relative to full length PLB-WT, indicating that the observed solubilization
of PLB truncation mutants is not due to proteolysis. Moreover, molecular dy-
namics simulations recapitulated the observed loss of stable bilayer anchoring
for truncated PLB. Fluorescence resonance energy transfer (FRET) analysis re-
vealed that C-terminal truncations resulted in progressive loss of PLB-PLB
FRET, indicating a decrease in the apparent affinity of PLB oligomerization.
We quantified a similar decrease in the SERCA-PLB binding affinity. Despite
this decrease in affinity, SERCA-PLB FRET was paradoxically increased by
deletion of up to 4 C-terminal residues as a result of a 14 angstrom decrease
